Report Categories
View AllRecent Articles
View All
Why Scinai SCNI deserves a deeper look right now Trend Weakens 20260508
EVR Evercore reports 466 percent Q1 2026 EPS beat shares rise 228 percent on positive investor sentiment
Merck Co MRK Spinoff Organon OGN Q1 2026 Earnings Miss Exposes Structural Growth Headwinds
How Assembly Bio ASMB benefits from the shifts in its industry 137 20260508
Bitcoin Dips Below 76000 as Iran Tensions Rise and ETF Outflows Accelerate
Tom Hardys Reported Exit From Mobland May Affect Paramount Series Production
Apollo Global and Blackstone Reportedly Working on 36 Billion Debt Financing for Anthropic
Consumer Strength Lifts Wall Street as Energy and Financials Drag
Silver Prices Slide on Wednesday May 27 2026 Market Trends and Implications
Anthropic Nears 1 Trillion Valuation After 65 Billion Series H Overtaking OpenAI
STSS Q3 2025 Earnings Losses Widen Sharply as Revenue Remains Absent
Energizer Holdings ENR Q1 2026 Earnings Staggering EPS Beat Lifts Shares
LCTX Q1 2026 Earnings EPS Miss Weighs on Sentiment as ClinicalStage Biotech Continues Pipeline Progress
VAALCO Energy Inc Q1 2026 Earnings Deep EPS Miss Highlights Operational Struggles
MAIN Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Declines
SSYS Q1 2026 Earnings NarrowerthanExpected Loss Drives Optimism
Sera Prognostics Surges 15 Bullish Momentum Meets Key Resistance at 217
Sentage Holdings Inc SNTG Edges Higher Amid Consolidation Near Key Resistance
CMSD Edges Higher Amid Steady Income Demand Technical Levels in Focus
BlackRock Taxable Municipal Bond Trust BBN Shows Modest Uptick as Price Hovers Near Midpoint of Key Range
First Mid Bancshares Holds Near Support Amid Modest Pullback
JE Cleantech Holdings JCSE Surges 64 Bullish Momentum Builds Toward Resistance
Oxford Square Capital Corp OXSQ Surges 78 Key Levels and Potential Drivers
Innoviz Technologies INVZ Nears Key Support Level as Decline Slows
Tenon Medical TNON MicroCap Stock Holds Steady Near Key Support Levels
Viatris VTRS Under Pressure Support Levels Tested After 15 Decline
Vera Therapeutics VERA Consolidates Near Support After Slight Decline